Vitolo, U., Falchi, L., Snauwaert, S., Offner, F., Nijland, M., Andersson, P., Patah, P., Altintas, I., Marek, J., Risum, M., Hao, Y., Brody, J. (2025). Fixed-duration epcoritamab in combination with bendamustine + Rituximab (BR) for first-line (1L) treatment of follicular lymphoma (FL): 3-year results from EPCORE NHL-2 arm 3 demonstrate deep and durable responses with manageable safety. Blood. https://doi.org/10.1182/blood-2025-5357